Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?
作者信息
Weekes Colin D, Clark Jeffrey W, Zhu Andrew X
机构信息
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
出版信息
Lancet Oncol. 2018 May;19(5):591-592. doi: 10.1016/S1470-2045(18)30249-3. Epub 2018 Apr 3.
Abstract
摘要
Zotero 插件